Definium Therapeutics Inc (DFTX) PT Raised to $72 at Wells Fargo
Tweet
Share
E-mailGet Alerts DFTX Hot Sheet
Price: $38.23 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 4 | New: 56
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 4 | New: 56
Join SI Premium – FREE
Wells Fargo analyst Benjamin Burnett raised the price target on Definium Therapeutics Inc (NASDAQ: DFTX) to $72.00 (from $68.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Citi Upgrades Thunder Software Technology (300496:CH) to Buy
- Wells Fargo Downgrades Vulcan Materials Company (VMC) to Underweight
- Nuvoco Vistas Corp Ltd (NUVOCO:IN) PT Lowered to INR435 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
